Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

ResMed Inc. (RMD) News - StockMarketCap

Stocks›ResMed Inc.☆

● At closeAs of Jul 2, 2026

ResMed Inc.

RMD✓

HealthcareMedical - DevicesNYSE

$209.63+4.24%

$30.41BMarket cap

18.77xP/E ratio

1.14MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$209.63

$8.53 (+4.24%) · 24h

Key metrics

Market cap$30.41B+4.53%

Enterprise value$27.45B

Volume (24h)1.14M

P/E ratio (TTM)18.77x

P/S ratio (TTM)5.10x

Dividend yield1.23%

Shares outstanding145.06M

Trading range

Previous close$201.10

Day range$203.15 - $209.66

52-week range$180.27 - $293.81

ResMed Inc. (RMD) operates in the Medical - Devices industry within the Healthcare sector, listed on NYSE.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news